MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.
about
Comparing the Effects of Krebs Plus Verapamil Solution on Endothelial Function of Harvested Human Greater Saphenous Vein with Heparinized Blood, an Invitro Study.Scaffold-Based microRNA Therapies in Regenerative Medicine and Cancer.miR-98 inhibits cell proliferation and induces cell apoptosis by targeting MAPK6 in HUVECs.Platelets activated by the anti-β2GPI/β2GPI complex release microRNAs to inhibit migration and tube formation of human umbilical vein endothelial cells.
P2860
MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
MicroRNA-26a targets MAPK6 to ...... graft neointimal hyperplasia.
@en
MicroRNA-26a targets MAPK6 to ...... graft neointimal hyperplasia.
@nl
type
label
MicroRNA-26a targets MAPK6 to ...... graft neointimal hyperplasia.
@en
MicroRNA-26a targets MAPK6 to ...... graft neointimal hyperplasia.
@nl
prefLabel
MicroRNA-26a targets MAPK6 to ...... graft neointimal hyperplasia.
@en
MicroRNA-26a targets MAPK6 to ...... graft neointimal hyperplasia.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-26a targets MAPK6 to ...... graft neointimal hyperplasia.
@en
P2093
Cuicui Liu
Juanjuan Tan
Liguo Yang
Zhiqiang Yan
P2860
P2888
P356
10.1038/SREP46602
P407
P577
2017-04-21T00:00:00Z